ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,775
0,17%
Bitcoin
59 696,56
0,99%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. AbCellera Biologics Inc (ABCL)

  7. AbCellera Biologics Inc (ABCL) Actualités

ABCL AbCellera Biologics Inc

3,87
0,0825 (2,18%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
AbCellera Biologics Inc ABCL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0825 2,18% 3,87 01:37:13
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,89 3,68 3,89 3,85 3,7875
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202415:00BWAbCellera, Viking Global Investors, and ArrowMark Partners..
08/4/202418:05BWAbCellera Presents Data on T-Cell Engagers Against Four..
03/4/202422:05BWAbCellera to Report First Quarter 2024 Financial Results on..
19/3/202421:05BWAbCellera to Present at the Bloom Burton Healthcare..
11/3/202414:00BWAbCellera to Collaborate with Biogen to Discover Therapeutic..
05/3/202422:30BWAbCellera Announces Four Presentations on T-Cell Engagers at..
27/2/202420:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:49EDGAR2Form 8-K - Current report
23/2/202422:30BWAbCellera Announces Resignation of Board Member
23/2/202402:15BWAbCellera to Present at Upcoming Investor Conferences in..
20/2/202422:49EDGAR2Form S-8 - Securities to be offered to employees in employee..
20/2/202422:27EDGAR2Form 8-K - Current report
20/2/202422:05BWAbCellera Reports Full Year 2023 Business Results
23/1/202422:05BWAbCellera to Report Full Year 2023 Financial Results on..
17/1/202400:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:05BWAbCellera to Present at the 42nd Annual J.P. Morgan..
20/12/202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202323:28EDGAR2Form 8-K - Current report
27/11/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202322:05BWAbCellera to Present at the Piper Sandler 35th Annual..
08/11/202321:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202317:05BWAbCellera Presents New Data on Two T-Cell Engager Programs..
02/11/202321:13EDGAR2Form 8-K - Current report
02/11/202321:05BWAbCellera Reports Q3 2023 Business Results
01/11/202321:05BWPrelude Therapeutics and AbCellera Enter Partnership to..
31/10/202321:05BWAbCellera to Present at the Jefferies London Healthcare..
11/10/202322:05BWAbCellera to Report Third Quarter 2023 Financial Results on..
27/9/202315:00BWAbCellera Announces Two T-Cell Engager Presentations at SITC..
20/9/202323:02BWAbCellera Expands Multi-Target Antibody Discovery..
20/9/202315:00BWAbCellera Expands Multi-Target Antibody Discovery..
14/9/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202315:00BWAbCellera Announces Collaboration with Incyte to Accelerate..
25/8/202319:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:15EDGAR2Form 8-K - Current report
03/8/202322:05BWAbCellera Reports Q2 2023 Business Results
24/7/202322:05BWAbCellera Announces that the U.S. Patent Trial and Appeal..
06/7/202322:05BWAbCellera to Report Second Quarter 2023 Financial Results on..
29/5/202322:05BWAbCellera to Present at the Goldman Sachs 44th Annual Global..
24/5/202319:10BWAbCellera Partners with the Governments of Canada and..
04/5/202322:05BWAbCellera Reports Q1 2023 Business Results

Dernières Valeurs Consultées

NASDAQ
ABCL
AbCellera Biologics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés